Nanoscope Therapeutics0 Like PostComments Off on Ophthalmology Times : Nanoscope Therapeutics presents results from phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa
Nanoscope Therapeutics0 Like PostComments Off on Global Genes: Nanoscope Reports Positive Topline Results from Phase 2b Trial of MCO-010 for the Treatment of Retinitis Pigmentosa
Nanoscope Therapeutics0 Like PostComments Off on Fierce Biotech: Nanoscope’s Phase 2Win for Gene Therapy Shows Potential of Light-sensitive Approach to Eye Disease
Nanoscope Therapeutics0 Like PostComments Off on Dallas Innovates: Nanoscope Therapeutics bolsters board with addition of ophthalmic veteran as strategic adviser
Nanoscope Therapeutics0 Like PostComments Off on The Future 50 in Dallas-Fort Worth 2023: Meet the Game-Changing Disruptors Driving Innovation and Impace
Nanoscope Therapeutics0 Like PostComments Off on Modern Retina: Nanoscope Therapeutics announces WHO selection of ‘sonpiretigene isteparvovec’ as international nonproprietary name for MCO-010
Nanoscope Therapeutics0 Like PostComments Off on Modern Retina: FDA grants fast track designation to Nanoscope Therapeutics for MCO-010 for the treatment of retinitis pigmentosa
Nanoscope Therapeutics0 Like PostComments Off on Ophthalmology Times: Enrollment Complete in STARLIGHT Phase 2 Clinical Trial of MCO-010 Optogenetic Gene Therapy for Stargardt Disease
Nanoscope Therapeutics0 Like PostComments Off on Ophthalmology Times: Nanoscope Therapeutics announces first patient dosed in STARLIGHT Phase 2 clinical trial of MCO-010 optogenetic gene therapy for Stargardt disease
This website uses cookies to improve your experience. By clicking "Accept", you consent to the use of ALL the cookies. However you may visit the Cookie Settings to provide a controlled consent. Cookie settingsAccept
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
